Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BEXAROTENE
- A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
- Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
- The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
- Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
- Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
- A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
- Bexarotene Amyloid Treatment for Alzheimer's Disease
- A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)
- Phase I Study of CS-7017 and Bexarotene
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract
- Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
- Preoperative Bexarotene Treatment for Cushing's Disease
- A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
- Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
- Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
- Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
- Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis
- Study of Bexarotene in Patients With Acute Myeloid Leukemia
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
- A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer
- Bexarotene With Narrow-Band UVB for Psoriasis
- Bexarotene Treatment in Schizophrenia
- Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
- Study of Tarceva and Targretin in Stage I-II Lung Cancer
- Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
- Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
- Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
- Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
- Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
- Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
- Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
- Bexarotene in Treating Patients With Metastatic Breast Cancer
- A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
Clinical trials list
click for details